Procter & Gamble Health (BOM:500126) Dividend Payout Ratio: 1.93 (As of Mar. 2026) — 451% Above Median

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Procter & Gamble Health Ltd BOM:500126

86 GF Score

Price ₹6,723.60

GF Value ₹6,080.91

Valuation Modestly Overvalued

6 Warning Signs

View Full Analysis

What is Procter & Gamble Health Dividend Payout Ratio?

Procter & Gamble Health BOM:500126 +0.30% 86 Dividend Payout Ratio is 1.93 as of Mar. 2026, which is 451% above its 10-year median of 0.35. GuruFocus rates BOM:500126 with a GF Score™ of 86/100 and a GF Value™ of ₹6,080.91 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 444 Drug Manufacturers companies, Procter & Gamble Health ranks worse than 84.23% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Procter & Gamble Health's Dividend Payout Ratio for the months ended in Mar. 2026 was 1.93.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Procter & Gamble Health Ltd is 0.79, which seems too high.

The historical rank and industry rank for Procter & Gamble Health's Dividend Payout Ratio or its related term are showing as below:

BOM:500126' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15 Med: 0.35 Max: 0.79
Current: 0.79

During the past 13 years, the highest Dividend Payout Ratio of Procter & Gamble Health was 0.79. The lowest was 0.15. And the median was 0.35.

BOM:500126's Dividend Payout Ratio is ranked worse than
84.23% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs BOM:500126: 0.79

As of today (2026-07-27), the Dividend Yield % of Procter & Gamble Health is 2.31%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Procter & Gamble Health was 3.32%. The lowest was 0.35%. And the median was 1.10%.

Procter & Gamble Health's Dividends per Share for the months ended in Mar. 2026 was ₹110.00.

During the past 12 months, Procter & Gamble Health's average Dividends Per Share Growth Rate was 10.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 33.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 43.80% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 40.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Procter & Gamble Health was 79.20% per year. The lowest was -72.10% per year. And the median was 36.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Procter & Gamble Health (BOM:500126) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Procter & Gamble Health Dividend Payout Ratio Related Terms

Procter & Gamble Health Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Procter & Gamble Health's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Health Dividend Payout Ratio Chart

Procter & Gamble Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Jun21

Jun22

Jun23

Jun24

Dividend Payout Ratio

Get a 7-Day Free Trial

0.25

0.38

0.68

0.41

0.75

Procter & Gamble Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividend Payout Ratio	Get a 7-Day Free Trial															2.17	0.00	0.84	0.00	1.93

BOM:500126 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procter & Gamble Health Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's Dividend Payout Ratio falls into.

Save Embed

86GF Score

Procter & Gamble Health Ltd BOM:500126

Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Procter & Gamble Health Dividend Payout Ratio Calculation

Procter & Gamble Health's Dividend Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jun. 2024 )	/	EPS without NRI (A: Jun. 2024 )
	=	100	/	133
	=	0.75

Procter & Gamble Health's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	110	/	56.99
	=	1.93

Frequently Asked Questions Learn more about Dividend Payout Ratio →

What does a Dividend Payout Ratio of 1.93 mean?

Procter & Gamble Health (BOM:500126) has a Dividend Payout Ratio of 1.93 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Procter & Gamble Health and its competitors. This is 451% above median its historical median of 0.35. Over the past decade, Procter & Gamble Health's Dividend Payout Ratio has ranged from 0.15 to 0.79. According to the industry distribution chart, Procter & Gamble Health ranks #374 out of 444 companies in the Drug Manufacturers industry, placing it in the top 84.2%.

Is Procter & Gamble Health's Dividend Payout Ratio too high?

Procter & Gamble Health's current Dividend Payout Ratio of 1.93 is 451% above median its 10-year median of 0.35. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 0.79. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Procter & Gamble Health's value of 1.93 is 407.9% above this industry median. Based on the distribution chart, Procter & Gamble Health ranks #374 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Procter & Gamble Health has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Procter & Gamble Health's Dividend Payout Ratio compare to ZTS?

According to the Drug Manufacturers industry distribution chart, Procter & Gamble Health ranks #374 out of 444 companies for Dividend Payout Ratio. This places Procter & Gamble Health in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Procter & Gamble Health's value of 1.93 is 407.9% above this benchmark. Historically, Procter & Gamble Health's own Dividend Payout Ratio has ranged from 0.15 to 0.79 over the past decade. While the company's 10-year median is 0.35 vs. the industry median of 0.38, Procter & Gamble Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividend Payout Ratio for a Drug Manufacturers company?

The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Health's current Dividend Payout Ratio of 1.93 is 407.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividend Payout Ratio mean?

A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Procter & Gamble Health and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Health's current Dividend Payout Ratio is 1.93, which is 451% above median its own 10-year median of 0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Procter & Gamble Health stock overvalued right now?

Based on GuruFocus' analysis, Procter & Gamble Health (BOM:500126) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6,080.91, compared to a current price of ₹6,723.60 — trading 10.6% above its estimated fair value. The current Dividend Payout Ratio is 1.93, which is 451% above median its 10-year median of 0.35 and 407.9% above the Drug Manufacturers industry median of 0.38. Procter & Gamble Health's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividend Payout Ratio calculated?

Dividend Payout Ratio is calculated from a company's financial statements. For Procter & Gamble Health (BOM:500126), the current Dividend Payout Ratio is 1.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Procter & Gamble Health (BOM:500126) Overvalued in 2026?

Based on GuruFocus' analysis, Procter & Gamble Health stock appears to be overvalued. The current stock price of ₹6,723.60 is trading 10.6% above its estimated GF Value™ of ₹6,080.91. GuruFocus considers Procter & Gamble Health to be Modestly Overvalued.

Key valuation signals for BOM:500126:

Dividend Payout Ratio: 1.93 (451% above median its 10-year median of 0.35)
GF Value™: ₹6,080.91 vs. price of ₹6,723.60 (10.6% above fair value)
GF Score™: 86/100 with 6 warning signs
Industry Position: 407.9% above the Drug Manufacturers median (#374 of 444)

No single metric tells the full story. See the BOM:500126 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Procter & Gamble Health Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:512529 BOM:544222 BOM:530549 NSE:STAR BOM:544619 BOM:530239 BOM:543322 BOM:530019 BOM:532872 BOM:531599 XTER:MRK TSE:4502 SHSE:600276 XSWX:GALD NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS HKSE:03692

Other Exchanges PGHL:India

Address Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099

Website https://www.pghealthindia.com

Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

86GF Score

Get the complete analysis for BOM:500126

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,723.60

Price

₹6,080.91

GF Value

View BOM:500126 Analysis

See Dividend Payout Ratio data for all stocks →